Cycle for Survival 2014
January 14, 2014
Our involvement with Cycle for Survival began three years ago when we approached the sarcoma department at Memorial Sloan-Kettering in order see if we could foster a research project focused on angiosarcoma. We were connected with Jen Linn, co-founder of Cycle for Survival, who inspired us to work the team at Cycle in order to […]
Red Sox Tickets winner collected her prize at the race today with number 305100.
May 4, 2013
Thank you all for your support!! Todays Oxford 5k was an amazing success. We will update soon when we have pictures in from our sister race in Troy
Angiosarcoma 5k road race in Troy MI
April 6, 2013
Our friend and advocate, Ryan Humphrey, has organized his own local 5k to correspond with our Oxford MA race on May 4th. Check out the details and see how you can become involved! http://www.troyasa5k.org
Angiosarcoma Awareness 5k Road Race!
February 12, 2013
Come join us for our 3rd annual 5k road race on May 4th at 9 am at the Oxford Public High School. Please check out our events section of more details. https://www.signmeup.com/site/reg/register.aspx?fid=K02VCJ7
Cycle for Survival!
January 14, 2013
Want to help raise funds to combat angiosarcoma? We are working with Memorial Sloan-Kettering and Cycle For Survival to raise funds in order to fund angiosarcoma research in Dr. Cristina Antonescu’s lab at MSKCC. Please see below for information regarding locations times and how to get involved! Special thanks to Ryan Humphrey for putting this […]
Dogs with hemangiosarcoma in a new clinical trial
November 28, 2012
Meet Memphis, the first dog enrolled in a new clinical trial aimed at curing hemangiosarcoma ( angiosarcoma, only in dogs). Dr. Jaime Modiano at the Univerity of Minnesota is overseeing this trial, which uses an investigational new drug that has been designed to specifically kill malignant hemangiosarcoma cells. Positive results from this trial could pave […]
The first ever clinical trial for Angiosarcoma is about to begin!
June 17, 2012
Because angiosarcoma is so rare, clinical trials designed specifically for this disease are typically not thought to be able to recruit enough patients. Angiosarcoma Awareness has been instrumental in allowing doctors to see that there is a population of angiosarcoma patients large enough to design trials. They have initiated the first NCI clinical trial for […]
Boston Herald Story on Angiosarcoma
May 29, 2012